BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33788858)

  • 1. Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study.
    Asai Y; Nguyen P; Hanna TP
    PLoS One; 2021; 16(3):e0248492. PubMed ID: 33788858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
    Slotman E; Schreuder K; Nijsten TEC; Wakkee M; Hollestein L; Mooyaart A; Siesling S; Louwman MWJ
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):680-687. PubMed ID: 35092107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
    Troesch A; Hoellwerth M; Forchhammer S; Del Regno L; Lodde G; Turko P; Cheng PF; Levesque ML; Hadaschik E; Livingstone E; Peris K; Flatz L; Koelblinger P; Dummer R; Dimitriou F
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):922-931. PubMed ID: 36785973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers-A Single-Center Study in Romania.
    Cocuz IG; Cocuz ME; Niculescu R; Șincu MC; Tinca AC; Sabău AH; Chiorean DM; Morariu SH; Cotoi OS
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34071770
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.
    Sangers TE; Wakkee M; Kramer-Noels EC; Nijsten T; Louwman MWJ; Jaspars EH; Hollestein LM
    Br J Dermatol; 2022 Aug; 187(2):196-202. PubMed ID: 35141890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
    Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
    JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to skin malignancies in COVID-19 pandemic days.
    Aslan Kayıran M; Karadag AS; Wollina U
    J Biol Regul Homeost Agents; 2020; 34(6):1977-1982. PubMed ID: 33111514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.
    Ferrara G; De Vincentiis L; Ambrosini-Spaltro A; Barbareschi M; Bertolini V; Contato E; Crivelli F; Feyles E; Mariani MP; Morelli L; Orvieto E; Pacella E; Venturino E; Saragoni L
    Am J Clin Pathol; 2021 Jan; 155(1):64-68. PubMed ID: 32995855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis.
    Díaz-Calvillo P; Muñoz-Barba D; Ureña-Paniego C; Maul LV; Cerminara S; Kostner L; Martínez López A; Arias-Santiago S
    Acta Derm Venereol; 2024 Mar; 104():adv19460. PubMed ID: 38483083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
    Tsibulak I; Reiser E; Bogner G; Petru E; Hell-Teutsch J; Reinthaller A; Weirather C; Weiss T; Bozsa S; Puschacher B; Hall M; Hittler D; Hrauda K; Thell E; Clauss S; Pozniak J; Alicke S; Gangl D; Gamperl G; Ebner C; Knoll K; Leitner K; Schilcher A; Schinnerl M; Sigl V; Singer C; Aigmüller T; Hofstätter B; Marth C
    Int J Gynecol Cancer; 2020 Nov; 30(11):1667-1671. PubMed ID: 33033166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.
    Swetter SM; Chang J; Shaub AR; Weinstock MA; Lewis ET; Asch SM
    JAMA Dermatol; 2017 Aug; 153(8):797-801. PubMed ID: 28593242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers.
    Marson JW; Maner BS; Harding TP; Meisenheimer J; Solomon JA; Leavitt M; Levin NJ; Dellavalle R; Brooks I; Rigel DS
    J Am Acad Dermatol; 2021 Apr; 84(4):1100-1103. PubMed ID: 33482258
    [No Abstract]   [Full Text] [Related]  

  • 16. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
    Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
    ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.
    De Vincentiis L; Carr RA; Mariani MP; Ferrara G
    J Clin Pathol; 2021 Mar; 74(3):187-189. PubMed ID: 32561524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada.
    Glazier RH; Green ME; Wu FC; Frymire E; Kopp A; Kiran T
    CMAJ; 2021 Feb; 193(6):E200-E210. PubMed ID: 33558406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
    Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
    Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The initial impact of the COVID-19 pandemic on the diagnosis of new cancers at a large pathology laboratory in the public health sector, Western Cape Province, South Africa.
    Van Wyk AC; De Jager LJ; Razack R; Van Wyk SS; Kleinhans W; Simonds HM; Schubert PT
    S Afr Med J; 2021 May; 111(6):570-574. PubMed ID: 34382569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.